Robert Hsu

Also affiliated with California Southern University, Los Angeles Medical Center, USC Norris Comprehensive Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Treatment approaches for FGFR-altered urothelial carcinoma: targeted therapies and immunotherapy”.

Treatment approaches for FGFR-altered urothelial carcinoma: targeted therapies and immunotherapy

Frontiers in Immunology(2023)10.3389/fimmu.2023.1258388

N/A

0.416DataRank · unranked

15 citations

Robert Hsu, David J. Benjamin

Molecular characterization of nectin-4 in non-small cell lung cancer subtypes.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e21119

N/A

0.165DataRank · unranked

2 citations

Nishant Gandhi, Chul Kim, Hirva Mamdani, Balázs Halmos, Ari M. Vanderwalde +5 more

Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e21000

N/A

0DataRank · unranked

0 citations

Yasmine Baca, Joanne Xiu, Rong‐Fu Wang, J. Nicholas Bodor, Chul Kim +8 more

Real world prognostic utility of body mass index and platelet lymphocyte ratio in first-line immunotherapy response in stage IV non-small cell lung cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e21092

N/A

0DataRank · unranked

0 citations

Robert Hsu, Darin Poei, Alexis Leyba, Krithika Chennapan, Christopher C. Leon +5 more